DFM:NIH Income Statement

Financials in millions KWD. Fiscal year is January - December.

Millions KWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	3.96	4.04	4.46	4.32	3.34	3.09
Other Revenue	5.35	4.13	3.49	2.52	2.51	-2.93
Revenue	9.31	8.18	7.95	6.84	5.85	0.16
Revenue Growth (YoY)	25.45%	2.82%	16.25%	16.92%	3620.84%	-98.09%
Cost of Revenue	2.88	2.94	3.39	3.39	2.39	2.24
Gross Profit	6.43	5.23	4.56	3.45	3.46	-2.08
Selling, General & Admin	1.72	1.6	1.73	1.57	1.53	1.32
Other Operating Expenses	0.04	0.03	0.03	0	-0.07	-0.04
Operating Expenses	1.76	1.63	1.75	1.58	1.46	1.28
Operating Income	4.67	3.61	2.8	1.87	1.99	-3.36
Interest Expense	-0.23	-0.22	-0.24	-0.16	-0.14	-0.15
Other Non Operating Income (Expenses)	-0.02	-0	-0	-	-0	-
EBT Excluding Unusual Items	4.42	3.38	2.56	1.71	1.85	-3.51
Gain (Loss) on Sale of Investments	-1.52	-1.52	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-0.01	-0.05	0.15
Asset Writedown	-	-	-	-	-0	-0.34
Pretax Income	2.91	1.87	2.56	1.7	1.8	-3.71
Income Tax Expense	0.01	0.01	0.01	0	0	-
Earnings From Continuing Operations	2.89	1.86	2.55	1.7	1.8	-3.71
Minority Interest in Earnings	-0.09	-0.22	-0.28	0.03	-0	-0.02
Net Income	2.8	1.64	2.28	1.72	1.79	-3.72
Net Income to Common	2.8	1.64	2.28	1.72	1.79	-3.72
Net Income Growth	26.64%	-28.04%	32.36%	-4.03%	-	-
Shares Outstanding (Basic)	245	243	242	231	224	230
Shares Outstanding (Diluted)	245	243	242	231	224	230
Shares Change (YoY)	1.26%	0.22%	5.02%	2.86%	-2.25%	-
EPS (Basic)	0.01	0.01	0.01	0.01	0.01	-0.02
EPS (Diluted)	0.01	0.01	0.01	0.01	0.01	-0.02
EPS Growth	25.08%	-28.21%	26.03%	-6.69%	-	-
Free Cash Flow	0.97	-1.19	-0.4	-0.85	0.91	-0.58
Free Cash Flow Per Share	0.00	-0.01	-0.00	-0.00	0.00	-0.00
Dividend Per Share	-	-	0.006	0.005	0.005	-
Dividend Growth	-	-	21.28%	2.17%	-	-
Gross Margin	69.06%	64.01%	57.31%	50.37%	59.08%	-
Operating Margin	50.16%	44.10%	35.25%	27.32%	34.10%	-2137.57%
Profit Margin	30.09%	20.06%	28.66%	25.17%	30.66%	-2367.45%
Free Cash Flow Margin	10.45%	-14.50%	-5.06%	-12.47%	15.49%	-371.15%
EBITDA	4.79	3.78	2.89	2.05	2.13	-3.13
EBITDA Margin	51.48%	46.29%	36.41%	29.97%	36.43%	-
D&A For EBITDA	0.12	0.18	0.09	0.18	0.14	0.23
EBIT	4.67	3.61	2.8	1.87	1.99	-3.36
EBIT Margin	50.16%	44.10%	35.25%	27.32%	34.10%	-
Effective Tax Rate	0.51%	0.30%	0.24%	0.00%	0.15%	-
Revenue as Reported	9.31	8.18	7.95	6.83	5.88	0

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.